Systemic lupus erythematosus following interferon therapy.
Flores
A
A
Olivé
A
A
Feliu
E
E
Tena
X
X
D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008180:Lupus Erythematosus, Systemic / Q000209:etiology*; D011994:Recombinant Proteins
D000974:Antibodies, Antinuclear; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins